Freschia Gonzales

Freschia Gonzales

Freschia is a News Writer for Key Media, contributing to Wealth Professional and Benefits and Pensions Monitor. She has also contributed to Australasian Lawyer and NZ Lawyer. She graduated with a Bachelor of Arts, majoring in International Studies from the University of San Jose Recoletos.

Starting her writing career in 2021, she has produced content for international audiences. In her spare time, Freschia critiques movies and series, follows musicals, and keeps up with pop culture.

LinkedIn | Email

FDA backlog raises scrutiny of Canada's outsourced drug inspections

Health Canada conducted only 15% of site inspections as it leaned on foreign regulators for oversight

FDA backlog raises scrutiny of Canada's outsourced drug inspections

More claims denied than approved as federal dental program stalls in clinics

Confusion over reimbursements and eligibility slows claims under Canada Dental Care Plan rollout

More claims denied than approved as federal dental program stalls in clinics

One in three Canadians now lives with obesity and coverage isn't keeping up

Pandemic stress drove weight gain in women and youth, with employers urged to rethink coverage gaps

One in three Canadians now lives with obesity and coverage isn't keeping up

Canada leads in remote work, but big banks tighten office mandates this September

RBC, Scotiabank, and BMO push four-day office returns as CEOs cite culture and strategy alignment

Canada leads in remote work, but big banks tighten office mandates this September

More than half of disabled Canadians report gaps in care as benefit rolls out

StatsCan links disability severity and accessibility barriers to higher unmet care needs in 2022

More than half of disabled Canadians report gaps in care as benefit rolls out

Summer jobs dry up as student unemployment hits highest level since 2009

Canada's jobless rate drops to 6.9% in June as part-time gains mask long-term labour strain

Summer jobs dry up as student unemployment hits highest level since 2009

Canada to become first major market for generic Ozempic

Hims & Hers targets 2026 launch as Novo Nordisk's semaglutide patent nears January expiry

Canada to become first major market for generic Ozempic

Canada braces for a costly reaction to Trump's pharmaceutical tariff talk

Canada's $7 billion drug exports face risk as Trump signals steep tariffs and pricing reform crackdown

Canada braces for a costly reaction to Trump's pharmaceutical tariff talk

Pay transparency is coming, but most aren't ready

Only 19% of companies feel ready for pay transparency, with compliance driving the push

Pay transparency is coming, but most aren't ready

OPSEU flags 10,000 college layoffs as international student cap hits Ontario campuses

Ontario colleges cut staff and suspend programs after international enrolment drops by 48%

OPSEU flags 10,000 college layoffs as international student cap hits Ontario campuses